Načítá se...
Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1: Rapidly Improving Stroke Symptoms (RISS): The “REexamining Acute Eligibility for Thrombolysis” (TREAT) Task Force
BACKGROUND AND PURPOSE: Since FDA approval of IV t-PA for treatment of acute ischemic stroke in 1996, it has become clear that several criteria used for exclusion from therapy were not based on actual data nor operationally defined for use in clinical practice. All eligibility criteria from the NIND...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3789593/ https://ncbi.nlm.nih.gov/pubmed/23847249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.000878 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|